Results demonstrate that embedding biological disease mechanisms within continuous-time deep learning improves the accuracy, biological plausibility, and clinical utility of long-horizon cognitive forecasting.
Abstract
Accurate long-term forecasting of cognitive trajectories across the Alzheimer's disease continuum is essential for early intervention, personalized prognosis, patient stratification, and clinical trial enrichment. Despite the promising predictive performance of recent longitudinal forecasting methods, they remain largely data-driven, struggle with irregularly sampled, incomplete longitudinal data and often neglect established disease biology, leading to biologically implausible trajectories. To address this, we propose a biologically constrained continuous-time framework for long-horizon cognition forecasting from limited baseline observations. The proposed method models the complete amyloid-tau-vascular-neurodegeneration-cognition (ATVNC) cascade using hierarchical Neural ODEs with biologically motivated monotonicity constraints. Each pathological stream is governed by a dedicated Neural ODE initialized from irregular longitudinal observations using a GRU-D encoder, capturing intrinsic disease evolution while being modulated by directed upstream pathological influences. A bounded cognition readout ensures physiologically valid cognitive score (MoCA) predictions, while teacher-student knowledge distillation improves learning from sparse longitudinal supervision. Evaluated on the ADNI dataset, the proposed framework achieves a long-horizon extrapolation MAE of 2.06 on 188 held-out participants while eliminating biologically implausible trajectory violations. It further demonstrates robust zero-shot cross-cohort generalization on OASIS-3 (MAE 2.68 on 300 participants), with fine-tuning improving MAE to 1.90. The model also supports prognostic enrichment for Alzheimer's clinical trials, achieving up to 2.70x enrichment over the cohort base rate. These results demonstrate that embedding biological disease mechanisms within continuous-time deep learning improves the accuracy, biological plausibility, and clinical utility of long-horizon cognitive forecasting. The code is publicly available at: https://github.com/PonDeepika/BEACON.
A variational Disease Progression Score (DPS) framework is introduced that maps multimodal biomarker dynamics onto a continuous latent timeline with quantified uncertainty, offering a probabilistic foundation for patient-level prognosis and precision monitoring in Alzheimer's disease.
T. Ngamsaowaros, I. Bodala, S. Michopoulou et al.· medRxiv· 0 citations
The heterogeneous progression of Alzheimer’s disease (AD) continuously challenges the
boundaries of traditional clinical neurology, particularly in early diagnosis and the personalized
administration of disease-modifying therapies. In recent years, the paradigm of the “digital twin” a
dynamic, data-driven in silico rep...
Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Ba...
Ying-Ying Zhang, Kun Zhao, Guodong Liu et al.· 0 citations
Neurodegenerative diseases, particularly Alzheimer's Disease and Parkinson's Disease, are rapidly increasing as one of the leading causes of disability, cognitive decline, and death among the elderly population worldwide. Accurately predicting long-term disease progression remains a significant research challenge due t...
Md. Ariful Islam, Moloy Biswas, Alif Laila et al.· Journal of Information Techn...· 0 citations
TIDE, a Treatment-Informed Dynamics Encoder, a diagonal continuous-time state space uses the true inter-observation interval as its integration step and lets the exogenous intervention channel modulate the decay eigenvalues, so an intervention alters the rate law rather than the level.
Juslin Franklin, Gopalakrishna Kanathur· Journal of Intelligent Decis...· 0 citations
Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.
Rubén Sanz-Blasco, M. Fernández-Blázquez, Emilio Verche et al.· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.